EcoDrugPlus

Carbonic Anhydrase 4-Like

Ensembl ID : ENSDCDG00000006968
Gene Symbol: LOC114793135
3 Cross references
215 Possible Orthologues:

Carbonic Anhydrase 5a

Ensembl ID : ENSDCDG00000023180
Gene Symbol: CA5A
3 Cross references
231 Possible Orthologues:

Carbonic Anhydrase 6

Ensembl ID : ENSDCDG00000029025
Gene Symbol: CA6
3 Cross references
230 Possible Orthologues:

Carbonic Anhydrase 7

Ensembl ID : ENSDCDG00000017572
Gene Symbol: CA7
3 Cross references
222 Possible Orthologues:

Carbonic Anhydrase Iv C

Ensembl ID : ENSDCDG00000032766
Gene Symbol: CA4C
1 Cross references
200 Possible Orthologues:

Casein Kinase 1 Epsilon

Ensembl ID : ENSDCDG00000004724
Gene Symbol: CSNK1E
3 Cross references
199 Possible Orthologues:

Caspase 9

Ensembl ID : ENSDCDG00000030560
Gene Symbol: CASP9
3 Cross references
204 Possible Orthologues:

Catechol O-Methyltransferase A-Like

Ensembl ID : ENSDCDG00000023828
Gene Symbol: LOC114797704
3 Cross references
168 Possible Orthologues:

Catechol O-Methyltransferase B-Like

Ensembl ID : ENSDCDG00000021086
Gene Symbol: LOC114800462
3 Cross references
211 Possible Orthologues:

Cathepsin C

Ensembl ID : ENSDCDG00000021058
Gene Symbol: CTSC
3 Cross references
239 Possible Orthologues:

Cathepsin K-Like

Ensembl ID : ENSDCDG00000022987
Gene Symbol: LOC114790893
3 Cross references
240 Possible Orthologues:

Cathepsin S-Like

Ensembl ID : ENSDCDG00000022985
Gene Symbol: LOC114789987
3 Cross references
237 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).